Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

US10238633B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Ralf Anderskewitz · Laupheim, DE
• Florian Paul Christian Binder · Maselheim, DE
• Matthias Grauert · Ingelheim am Rhein, DE
• Marc Grundl · Biberach an der Riß, DE
• Peter Wilhelm HAEBEL · Mittelbiberach, DE
• Thorsten Oost · Biberach an der Riß, DE
• Alexander Pautsch · Ulm, DE
• Stefan Peters · Biberach an der Riß, DE
• Viktor Vintonyak · Warthausen, DE

Key dates

• Filing date: Jun 6, 2017
• Grant date: Mar 26, 2019
• Expiry date: Jun 6, 2037

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.